Cargando…

Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder

Schizophrenia and bipolar disorder share a number of common features, both symptomatically and biologically. Abnormalities in the neuroimmune and the stress-signaling pathways have been previously identified in brains of individuals with both diseases. However, the possible relationship between abno...

Descripción completa

Detalles Bibliográficos
Autores principales: Fillman, S G, Sinclair, D, Fung, S J, Webster, M J, Shannon Weickert, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944638/
https://www.ncbi.nlm.nih.gov/pubmed/24569695
http://dx.doi.org/10.1038/tp.2014.8
_version_ 1782306416815505408
author Fillman, S G
Sinclair, D
Fung, S J
Webster, M J
Shannon Weickert, C
author_facet Fillman, S G
Sinclair, D
Fung, S J
Webster, M J
Shannon Weickert, C
author_sort Fillman, S G
collection PubMed
description Schizophrenia and bipolar disorder share a number of common features, both symptomatically and biologically. Abnormalities in the neuroimmune and the stress-signaling pathways have been previously identified in brains of individuals with both diseases. However, the possible relationship between abnormalities in stress and neuroimmune signaling within the cortex of people with psychotic illness has not been defined. To test the hypothesis that combined alterations in brain stress responsiveness and neuroimmune/inflammatory status are characteristic of some individuals suffering from major mental illness, we examined gene expression in the Stanley Array Cohort of 35 controls, 35 individuals with schizophrenia and 34 individuals with bipolar disorder. We used levels of 8 inflammatory-related transcripts, of which SERPINA3 was significantly elevated in individuals with schizophrenia (F(2,88)=4.137, P<0.05), and 12 glucocorticoid receptor signaling (stress) pathway transcripts previously examined, to identify two clusters of individuals: a high inflammation/stress group (n=32) and a low (n=68) inflammation/stress group. The high inflammation/stress group has a significantly greater number of individuals with schizophrenia (n=15), and a trend toward having more bipolar disorder individuals (n=11), when compared with controls (n=6). Using these subgroups, we tested which microarray-assessed transcriptional changes may be associated with high inflammatory/stress groups using ingenuity analysis and found that an extended network of gene expression changes involving immune, growth factors, inhibitory signaling and cell death factors also distinguished these groups. Our work demonstrates that some of the heterogeneity in schizophrenia and bipolar disorder may be partially explained by inflammation/stress interactions, and that this biological subtype cuts across Diagnostic and Statistical Manual of Mental Disorders (DSM)-defined categories.
format Online
Article
Text
id pubmed-3944638
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39446382014-03-06 Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder Fillman, S G Sinclair, D Fung, S J Webster, M J Shannon Weickert, C Transl Psychiatry Original Article Schizophrenia and bipolar disorder share a number of common features, both symptomatically and biologically. Abnormalities in the neuroimmune and the stress-signaling pathways have been previously identified in brains of individuals with both diseases. However, the possible relationship between abnormalities in stress and neuroimmune signaling within the cortex of people with psychotic illness has not been defined. To test the hypothesis that combined alterations in brain stress responsiveness and neuroimmune/inflammatory status are characteristic of some individuals suffering from major mental illness, we examined gene expression in the Stanley Array Cohort of 35 controls, 35 individuals with schizophrenia and 34 individuals with bipolar disorder. We used levels of 8 inflammatory-related transcripts, of which SERPINA3 was significantly elevated in individuals with schizophrenia (F(2,88)=4.137, P<0.05), and 12 glucocorticoid receptor signaling (stress) pathway transcripts previously examined, to identify two clusters of individuals: a high inflammation/stress group (n=32) and a low (n=68) inflammation/stress group. The high inflammation/stress group has a significantly greater number of individuals with schizophrenia (n=15), and a trend toward having more bipolar disorder individuals (n=11), when compared with controls (n=6). Using these subgroups, we tested which microarray-assessed transcriptional changes may be associated with high inflammatory/stress groups using ingenuity analysis and found that an extended network of gene expression changes involving immune, growth factors, inhibitory signaling and cell death factors also distinguished these groups. Our work demonstrates that some of the heterogeneity in schizophrenia and bipolar disorder may be partially explained by inflammation/stress interactions, and that this biological subtype cuts across Diagnostic and Statistical Manual of Mental Disorders (DSM)-defined categories. Nature Publishing Group 2014-02 2014-02-25 /pmc/articles/PMC3944638/ /pubmed/24569695 http://dx.doi.org/10.1038/tp.2014.8 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Original Article
Fillman, S G
Sinclair, D
Fung, S J
Webster, M J
Shannon Weickert, C
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
title Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
title_full Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
title_fullStr Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
title_full_unstemmed Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
title_short Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
title_sort markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944638/
https://www.ncbi.nlm.nih.gov/pubmed/24569695
http://dx.doi.org/10.1038/tp.2014.8
work_keys_str_mv AT fillmansg markersofinflammationandstressdistinguishsubsetsofindividualswithschizophreniaandbipolardisorder
AT sinclaird markersofinflammationandstressdistinguishsubsetsofindividualswithschizophreniaandbipolardisorder
AT fungsj markersofinflammationandstressdistinguishsubsetsofindividualswithschizophreniaandbipolardisorder
AT webstermj markersofinflammationandstressdistinguishsubsetsofindividualswithschizophreniaandbipolardisorder
AT shannonweickertc markersofinflammationandstressdistinguishsubsetsofindividualswithschizophreniaandbipolardisorder